Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 415
Selected: 0
NCT IDTitle
NCT00193882Advanced Oesophageal Cancer Study to Compare Quality of Life and Palliation of Dysphagia.
NCT02414022Economic Analysis of Alliance A041202 CLL Study
NCT00040183OSI-774 (Tarceva) Plus Gemcitabine in Patients With Locally Advanced, Unresectable or Metastatic Pancreatic Cancer.
NCT03233711Nivolumab After Combined Modality Therapy in Treating Patients With High Risk Stage II-IIIB Anal Cancer
NCT02125006The Effect of an Inter-Disciplinary Program, Including MBSR, in Breast Cancer Survivors With Chronic Neuropathic Pain
NCT06323707The IMPACT Implementation-Effectiveness Trial
NCT01506687Increasing Colorectal Cancer Screening Uptake With a Patient Navigator
NCT03055871Parents and Children Active Together Study
NCT05452824Participating in Tai Chi to Reduce Anxiety and Keep up Physical Function
NCT02870920Durvalumab and Tremelimumab and Best Supportive Care vs Best Supportive Care in Patients With Advanced Colorectal Cancer
NCT01152788Phase II Study of Interleukin-21 (rIL-21) vs Dacarbazine (DTIC) in Patients With Metastatic or Recurrent Melanoma
NCT04176848CFI-400945 and Durvalumab in Patients With Advanced Triple Negative Breast Cancer
NCT00343408AZD2171 and Standard Combination Chemotherapy in Advanced Non-Small Cell Lung Cancer or Colorectal Cancer
NCT03917082Limited Adjuvant Endocrine Therapy for Low Risk Breast Cancer
NCT04746859Evaluation of the Effectiveness and Implementation of the BETTER Women Peer Health Coaching Program
NCT00026338Gemcitabine With/Out Erlotinib in Unresectable Locally Advanced/Metastatic Pancreatic Cancer
NCT01068587MET/VEGFR2 Inhibitor GSK1363089 and Erlotinib Hydrochloride or Erlotinib Hydrochloride Alone in Locally Advanced or Metastatic NSCLC That Has Not Responded to Previous Chemotherapy
NCT04685616Brentuximab Vedotin in Early Stage Hodgkin Lymphoma
NCT00002583Vinorelbine + Cisplatin or No Further Therapy in Non-small Cell Lung Cancer That Has Been Surgically Removed
NCT03585634The Dads in Gear Program: An Innovative Men-centered Approach to Smoking Cessation
NCT01515787PROSPECT: Chemotherapy Alone or Chemotherapy Plus Radiation Therapy in Treating Patients With Locally Advanced Rectal Cancer Undergoing Surgery
NCT02225015Cancer Prevention in Women With a BRCA Mutation
NCT03480776ASA in Prevention of Ovarian Cancer (STICs and STONEs)
NCT00770185Ridaforolimus in Treating Patients With Recurrent Metastatic and/or Locally Advanced Endometrial Cancer
NCT03748550Exercise to Prevent AnthraCycline-based Cardio-Toxicity Study 2.0 (EXACT2)
NCT00640471Cetuximab With or Without Brivanib in Treating Patients With K-Ras Wild Type Tumours and Metastatic Colorectal Cancer
NCT00245154Paclitaxel + Carboplatin With/Out Cediranib Maleate in Stage III or Stage IV Non-Small Cell Lung Cancer
NCT00053794Perifosine in Treating Patients With Metastatic or Locally Advanced Soft Tissue Sarcoma
NCT03461952Nivolumab Ipilimumab in Patients With hyperMutated Cancers Detected in Blood (NIMBLe)
NCT05371808Economic Analysis of Early vs Delayed Therapy in Newly Diagnosed Asymptomatic High-Risk Patients With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma:
NCT01145989A Study of AT9283 in Patients With Relapsed or Refractory Multiple Myeloma
NCT00093457Sorafenib in Treating Patients With Metastatic or Recurrent Prostate Cancer
NCT00490139ALTTO (Adjuvant Lapatinib And/Or Trastuzumab Treatment Optimisation) Study; BIG 2-06/N063D
NCT00002866Docetaxel and Epirubicin With and Without G-CSF in Treating Women With Metastatic Breast Cancer
NCT03938987Anti-CD19, Dual Co-stimulatory (4-1BB, CD3ζ) Chimeric Antigen Receptor T-cells in Patients With Relapsed/Refractory Aggressive Lymphoma or Acute Lymphoblastic Leukemia (ALL)
NCT03259035NEO: Neoadjuvant Chemotherapy, Excision and Observation for Early Rectal Cancer
NCT02905318Palbociclib in Patients With Metastatic Castration-Resistant Prostate Cancer
NCT03271892Deciding on Active Surveillance or Surgery for Primary Management of Low Risk Papillary Thyroid Cancer
NCT01708993Reolysin in Previously Treated Advanced/Metastatic, Non Small Cell Lung Cancer Receiving Standard Salvage Therapy
NCT00006036Liposomal Lurtotecan Plus Cisplatin in Treating Patients With Advanced or Metastatic Solid Tumors
NCT01972984Feasibility Study of Presurgical Hormone Therapy (Anastrozole) in Breast Cancer Patients
NCT00003684Theophylline in Treating Cancer Patients With Shortness of Breath
NCT02512965Study Comparing Stereotactic Body Radiotherapy vs Conventional Palliative Radiotherapy (CRT) for Spinal Metastases
NCT04650581Fulvestrant and Ipatasertib for Advanced HER-2 Negative and Estrogen Receptor Positive (ER+) Breast Cancer Following Progression on First Line CDK 4/6 Inhibitor and Aromatase Inhibitor
NCT03258554Radiation Therapy With Durvalumab or Cetuximab in Treating Patients With Locoregionally Advanced Head and Neck Cancer Who Cannot Take Cisplatin
NCT02003222Combination Chemotherapy With or Without Blinatumomab in Treating Patients With Newly Diagnosed BCR-ABL-Negative B Lineage Acute Lymphoblastic Leukemia
NCT05255653Refining Adjuvant Treatment IN Endometrial Cancer Based On Molecular Features
NCT04771975Connecting Breast Cancer Survivors for Exercise
NCT00377052Bortezomib and Gemcitabine in Treating Patients With Relapsed Mantle Cell Lymphoma
NCT01622543Reolysin in Combination With FOLFOX6 and Bevacizumab or FOLFOX6 and Bevacizumab Alone in Metastatic Colorectal Cancer